Bolt Biotherapeutics Inc (NAS:BOLT)
$ 0.635 -0.0068 (-1.06%) Market Cap: 24.30 Mil Enterprise Value: -30.54 Mil PE Ratio: 0 PB Ratio: 0.28 GF Score: 37/100

Bolt Biotherapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript

Feb 16, 2023 / 08:40PM GMT
Release Date Price: $1.42 (+1.43%)
Jeff La Rosa
SVB Securities - Analyst

Good morning, everyone. My name is Jeff La Rosa. I am an equity research associate here on the immuno-oncology team, SVB Securities. And I'm pleased to welcome Bolt Biotherapeutics to the last day of our Annual Biopharma Healthcare Conference. Here with me to present their story is Randy Schatzman, CEO. We'll be joined by Edith Perez, CMO; and Willie Quinn, CFO.

(Conference Instructions) With that, Randy, the floor is yours.

Randy Schatzman
Bolt Biotherapeutics, Inc. - President & CEO

Thank you, Jeff. Thanks for the kind introduction and thanks to the team at SVB Securities for inviting us to participate in the conference this week.

As Jeff mentioned, I'm joined today by Willie Quinn, who's Bolt's Chief Financial Officer; and Edith Perez, who is our Chief Medical Officer. And we'll be happy to -- and actually look forward to answering Jeff's questions after my opening remarks. So we will be making forward-looking statements today, and I encourage listeners to go to our filings with the SEC to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot